To main content

COBIOPHAD

COBIOPHAD

In the EU alone, around 2.5 million people are allergic to β-lactam antibiotics and this figure increases every year due to excessive drug intake. The main objective of COBIOPHAD project is the development of an integrated biophotonic device based on compact disc technology to address the most prevalent drug allergies

The system will be developed in a low cost and rapid point-of-care format and will integrate multiple key enabling technologies – advanced materials, centrifugal microfluidics, optics, electronics, bio-analytical tools, manufacturing technologies, and cloud-based data networking. The project targets a highly sensitive, selective, and multiplexed in vitro medical diagnostic device that will contribute to the sustainability of healthcare systems and the life quality of millions of European citizens suffering drug allergies.

The COBIOPHAD is a large-scale project consisting of ten partners from seven European countries, including research institutions, manufacturers and hospitals. It is coordinated by Universitat Politècnica de València (Spain). SINTEF's role is the microfluidic design and prototyping of disposable, centrifugal cartridges used in analysis of patients' samples. The project is supported by the EC (grant # 688448) and the Photonics Public Private Partnership [PPP].

Published 26 September 2018
Senior Research Scientist

Project duration

2016 - 2018